CCL2 and depressive symptom measurement: Another small study compared 44 patients with depression to 21 patients with neurological symptoms and found no significant group differences regarding CSF levels of IL-4, MCP-1 and MIP-1β [38], whereas a study found higher CSF MCP-1 levels to be associated with more severe depressive symptoms in patients with Parkinson’s disease [39].